AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Data demonstrate HPV testing catches more serious cervical disease.

Women's Health Weekly

| April 01, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 APR 1 - (NewsRx.com & NewsRx.net) -- A growing body of data demonstrating the ability of HPV (human papillomavirus) testing to identify women at high risk of cervical cancer more accurately than the most advanced type of Pap test was presented at an international medical conference in Mexico City, announced Digene Corp. (DIGE).

In recognition of these research findings, some experts are recommending that the HPV test replace the Pap as the first-line tool for cervical cancer screening, particularly in low-resource countries in the developing world.

Speaking as an invited lecturer at the 21st Annual Papillomavirus Conference & Clinical Workshop, professor Jack Cuzick, PhD, head of epidemiology for Cancer Research U.K. at Queen Mary's College in London, said: "The general principal is that screening should be performed as infrequently as possible using the best available test. There is no doubt that the HPV DNA test is more sensitive than cytology (Pap testing). This has been shown in every study conducted, using both conventional and liquid-based cytology."

Cuzick concluded that the available evidence supports a recommendation that the high-risk HPV DNA test be used as the primary tool for cervical cancer screening, with the Pap performed only in women who test positive for the human papillomavirus - which causes virtually all cases of cervical cancer. To further research this proposal, he announced he is planning a European primary-screening study involving one million women.

Digene's DNAwithPap Test is the only test for high-risk types of HPV approved by the U.S. Food and Drug Administration (FDA). It is approved in the United States for use in conjunction with the Pap test in women age 30 and older, as well as for follow-up evaluation in women whose Pap results are uncertain.

In a ...

Related articles from newspapers, magazines, journals, and more
HPV/DNA Testing -- Will Traditional PAP Smear Screening Become Obsolete?
Press release article from: PR Newswire January 12, 2004 700+ words
...subject of a marketing research study "HPV/DNA Gynecologic Testing Report" that is now...care market research firm. The use of HPV/DNA testing has entered clinical use in cervical...receiving approval earlier last year. The HPV/DNA Gynecologic Testing Report suggests that...
HPV DNA microarray may be useful for diagnosing, typing HPV in large studies.
Newspaper article from: Obesity, Fitness & Wellness Week September 25, 2004 700+ words
...NewsRx.net) -- Human papillomavirus (HPV) DNA microarray may be useful for diagnosing...genotype spectrum discriminated by this HPV DNA microarray includes 15 high-risk HPV...GenomicTree Inc., Taejon, reported, "The HPV DNA microarray showed high degrees of specificity...
The HPV DNA virus hybrid capture assay: what is it--and where do we go from...
Magazine article from: Medical Laboratory Observer Vernick, John P. Steigman, Carmen K. March 1, 2003 700+ words
...or more older than women with HSIL. This...further defined. HPV DNA testing could have...ongoing testing of women at periodic intervals. Finally, HPV DNA testing might be...predictive value of HPV DNA testing would be...post-menopausal women diagnosed with ASC...
Spanish Medical Societies Issue First European National Consensus Guidelines...
Press release article from: PR Newswire December 14, 2006 700+ words
...guidelines that recommend HPV DNA testing for routine, primary screening for women over 35, announced...In addition to HPV DNA testing for primary...appropriate use of the HPV DNA test ... would be...Pap testing only of women with HPV." The guidelines...
Screen Semen Donations for HPV DNA.
Magazine article from: OB GYN News BOSCHERT, SHERRY September 1, 2000 700+ words
...PCR) tests found human papilomavirus (HPV) DNA sequences in sperm samples from 24 (53...It could be prevented by screening for HPV DNA as rapid and sensitive PCR tests become...sensitive in predicting the absence of HPV DNA in sperm cells. Laboratory techniques...
Reflex HPV DNA testing not useful for cytologic diagnoses of LSIL or AGC-NOS.
Newspaper article from: TB & Outbreaks Week August 24, 2004 700+ words
...papillomavirus (HPV) DNA is now a viable option...the management of women with atypical squamous...utility of reflexive HPV DNA testing for women with a cytologic...Prevalence and typing of HPV DNA by hybrid capture II in women with ASCUS, ASC...
New Consensus Guidelines State Reflex HPV DNA Testing Preferred Approach for...
Press release article from: Business Wire April 24, 2002 700+ words
...note, "Requiring women to return to collect a sample for HPV DNA testing or repeat...observed, "Reflex HPV DNA testing offers significant...advantages since women do not need an additional...examination. Moreover, women testing negative for HPV DNA can rapidly be ...
HiFi DNA Tech Tells FDA It is "Unreasonable" and Should Study the Science of...
Press release article from: Business Wire April 14, 2008 700+ words
...unfortunately does not benefit women who may have HPV." The Memorandum...a petition to reclassify an HPV DNA PCR (polymerase chain reaction...design is a critical process for HPV DNA testing because of the large...lawsuit because neither the HPV DNA PCR device, nor the ...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA